Holen Sie sich die Stockscreener-App
1.64
3.80%
-0.07
Handel nachbörslich:
1.64
Schlusskurs vom Vortag:
$1.71
Offen:
$1.7
24-Stunden-Volumen:
44,075
Relative Volume:
1.48
Marktkapitalisierung:
$66.15M
Einnahmen:
$1.88M
Nettoeinkommen (Verlust:
$-15.57M
KGV:
-4.10
EPS:
-0.4
Netto-Cashflow:
$-50.09M
1W Leistung:
-8.36%
1M Leistung:
-9.62%
6M Leistung:
+40.60%
1J Leistung:
-33.94%
1-Tages-Spanne:
$1.62
$1.7031
1-Wochen-Bereich:
$1.62
$1.86
52-Wochen-Spanne:
$0.98
$3.44
Beyondspring Inc Stock (BYSI) Company Profile
Firmenname
Beyondspring Inc
Sektor
Branche
Telefon
646-528-4184
Adresse
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Vergleichen Sie BYSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
1.64 | 68.95M | 1.88M | -15.57M | -50.09M | -0.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-02 | Herabstufung | Jefferies | Buy → Hold |
| 2021-12-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-12-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-09-09 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-08-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-04-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-01-11 | Eingeleitet | BofA Securities | Buy |
| 2020-12-29 | Eingeleitet | Evercore ISI | Outperform |
| 2020-02-07 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Nomura | Buy |
| 2019-12-03 | Eingeleitet | William Blair | Outperform |
| 2019-07-10 | Bestätigt | H.C. Wainwright | Buy |
| 2019-04-30 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-10-25 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Beyondspring Inc Aktie (BYSI) Neueste Nachrichten
How to track smart money flows in BeyondSpring Inc.July 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
Will BeyondSpring Inc. price bounce be sustainableWeekly Profit Report & Daily Stock Momentum Reports - newser.com
BeyondSpring Inc. stock trend forecast2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Real time alert setup for BeyondSpring Inc. performanceEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
What earnings revisions data tells us about BeyondSpring Inc.July 2025 Outlook & Free Safe Capital Growth Stock Tips - newser.com
What technical models suggest about BeyondSpring Inc.’s comeback - newser.com
Reversal indicators forming on BeyondSpring Inc. stockTrade Risk Report & Smart Money Movement Alerts - newser.com
What machine learning models say about BeyondSpring Inc.2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Decheng Capital sells BeyondSpring (BYSI) shares for $24,719 By Investing.com - Investing.com Canada
Decheng Capital sells BeyondSpring (BYSI) shares for $24,719 - Investing.com
What’s the recovery path for long term holders of BeyondSpring Inc.Weekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com
BeyondSpring (NASDAQ:BYSI) Receives Sell (D) Rating from Weiss Ratings - MarketBeat
Analyzing BeyondSpring Inc. with risk reward ratio chartsJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com
Decheng Capital sells BeyondSpring (BYSI) shares for $35,965 - Investing.com
T 0792/24: Novelty And Inventiveness Of Second Medical Use ClaimsPatentUnited Kingdom - Mondaq
Published on: 2025-10-06 05:59:14 - newser.com
Price momentum metrics for BeyondSpring Inc. explained2025 Top Decliners & Community Verified Trade Alerts - newser.com
Order flow analysis tools used on BeyondSpring Inc.July 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Can BeyondSpring Inc. stock deliver surprise earnings beatJobs Report & High Accuracy Swing Entry Alerts - newser.com
Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech
Decheng capital funds sell $3,045 in BeyondSpring (BYSI) shares By Investing.com - Investing.com Nigeria
Decheng capital funds sell $3,045 in BeyondSpring (BYSI) shares - Investing.com
Published on: 2025-09-29 02:12:06 - newser.com
What analysts say about BeyondSpring Inc stockVolume Analysis Techniques & Free ETF and Mutual Fund Comparisons - earlytimes.in
Why Soligenix Inc. (DOA0) stock remains top ratedTrade Volume Report & Risk Controlled Daily Plans - newser.com
Is Kongsberg Gruppen ASA (Common Stock) (KOZ0) stock a top hedge fund pickWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Is PubMatic Inc. stock safe for conservative investors2025 Market Overview & Free Real-Time Volume Trigger Notifications - newser.com
China Natural Resources Inc. stock daily chart insightsRecession Risk & Weekly Chart Analysis and Guides - newser.com
Published on: 2025-09-27 12:36:33 - newser.com
Decheng Capital funds sell $20,752 in BeyondSpring (BYSI) shares - Investing.com India
Decheng Capital funds sell $20,752 in BeyondSpring (BYSI) shares By Investing.com - Investing.com South Africa
Finanzdaten der Beyondspring Inc-Aktie (BYSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Beyondspring Inc-Aktie (BYSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Decheng Capital China Life Sci | 10% Owner |
Oct 09 '25 |
Sale |
1.81 |
3,979 |
7,202 |
1,806,410 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 10 '25 |
Sale |
1.77 |
2,390 |
4,230 |
1,804,020 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 06 '25 |
Sale |
1.78 |
17,500 |
31,150 |
1,819,996 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 07 '25 |
Sale |
1.79 |
2,100 |
3,759 |
1,817,896 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 03 '25 |
Sale |
1.76 |
600 |
1,056 |
1,837,496 |
| Decheng Capital China Life Sci | 10% Owner |
Sep 30 '25 |
Sale |
1.81 |
4,464 |
8,080 |
1,841,297 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 01 '25 |
Sale |
1.80 |
2,601 |
4,682 |
1,838,696 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 02 '25 |
Sale |
1.73 |
600 |
1,038 |
1,838,096 |
| Decheng Capital China Life Sci | 10% Owner |
Sep 25 '25 |
Sale |
1.66 |
700 |
1,162 |
1,846,861 |
| Decheng Capital China Life Sci | 10% Owner |
Sep 26 '25 |
Sale |
1.68 |
600 |
1,008 |
1,846,261 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):